Altered Bone Mass and Turnover in Female Patients with Adrenal Incidentaloma: The Effect of Subclinical Hypercortisolism
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The strategy of treatment for patients with adrenal incidentalomas (AI) may depend upon the presence of hormonal hypersecretion. Although alterations of bone turnover have been recently reported, data on bone mineral density (BMD) are not available in AI patients. We evaluated bone turnover and BMD in 32 female AI patients and 64 matched controls. Spinal and femoral BMD were similar in patients and controls. Serum bone GLA protein (6.8+/-3.5 vs. 8.8+/-3.2 ng/mL; P<0.005) and PTH (48.8+/-15.1 vs. 37.2+/-10.9 pg/mL; P<0.0001) were different in patients and controls. Patients were then subdivided into 2 groups: with (n = 8; group A) or without (n = 24; group B) subclinical hypercortisolism. PTH was higher (P<0.05) in group A than in group B and in both groups than in controls (57.1+/-13.6, 46.0+/-14.8, and 37.2+/-10.9 pg/mL, respectively), and bone GLA protein was lower in group A than in group B and controls (3.8+/-2.3, 7.5+/-3.1, and 8.8+/-3.2 ng/mL, respectively; P<0.05). Serum type I cross-linked C telopeptide and fasting urinary deoxypyridinoline/ creatinine were not different in the three groups. BMD at each site was lower (P<0.05) in group A than in group B and controls. Bone mass and metabolism are altered in AI patients with subclinical hypercortisolism and should be taken into account, therefore, when addressing the treatment of choice for these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Few studies reported a high frequency (i.e. higher than 25%) of elevated UFC levels in patients with AI (21,43,48,49,53,60).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [43]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, in patients with ACS, a mixed picture is reported with either decreased, normal, or even increased bone formation reported alongside normal bone resorption (229,242,259-262).”
From Adrenal incidentaloma (2020) · cites this paper as [259]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Low serum ACTH levels are frequently found in AI patients (19,21,32,36,40,43,44,48,49,56,60,61).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [43]
In the citing paper
“Both trabecular (65,261-263) and cortical (259,262,264-266) bone loss have been described in patients with ACS.”
From Adrenal incidentaloma (2020) · cites this paper as [259]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Incidentally Discovered Adrenal Masses*
KLOOS, R. T., GROSS, M. D., FRANCIS, I. R., KOROBKIN, M., & SHAPIRO, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-4-460 · Cited by 828
Molecular Basis and Clinical Application of Biological Markers of Bone Turnover*
CALVO, M. S., EYRE, D. R., & GUNDBERG, C. M. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-4-333 · Cited by 518
Reincke, M. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.3.826 · Cited by 348
Nonfunctioning adrenal masses: incidental discovery on computed tomography
Glazer, H., Weyman, P., Sagel, S., Levitt, R., & McClennan, B. (1982) · American Journal of Roentgenology · doi:10.2214/ajr.139.1.81 · Cited by 347
Hormonal Evaluation of the Patient with an Incidentally Discovered Adrenal Mass
Desforges, J. F., Ross, N. S., & Aron, D. C. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011153232007 · Cited by 340
Incidentally DiscoveredAdrenal Mass
Young, W., & Bancos, I. (2023) · Adrenal Disorders · doi:10.1016/b978-0-323-79285-1.00101-1 · Cited by 304
Angeli, A., Osella, G., Ali, A., & Terzolo, M. (1997) · Hormone Research · doi:10.1159/000185477 · Cited by 259
Serendipitous adrenal masses: Prevalence, significance, and management
Abecassls, M., McLoughlin, M. J., Langer, B., & Kudlow, J. E. (1985) · The American Journal of Surgery · doi:10.1016/s0002-9610(85)80186-0 · Cited by 233
Normal Reference Laboratory Values
Kratz, A., & Lewandrowski, K. B. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391508 · Cited by 209
Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas)
Osella, G., Terzolo, M., Borretta, G., Magro, G., Alí, A., Piovesan, A., Paccotti, P., & Angeli, A. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.6.7989452 · Cited by 206
Cited by
The clinically inapparent adrenal mass: update in diagnosis and management
Mansmann, G., Lau, J., Balk, E., Rothberg, M., Miyachi, Y., & Bornstein, S. R. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0031 · Cited by 781
MANAGEMENT APPROACHES TO ADRENAL INCIDENTALOMAS
Young, W. F. (2000) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70122-5 · Cited by 415
Tauchmanovà, L., Rossi, R., Biondi, B., Pulcrano, M., Nuzzo, V., Palmieri, E.-A., Fazio, S., & Lombardi, G. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011766 · Cited by 400
Sherlock, M., Scarsbrook, A., Abbas, A., Fraser, S., Limumpornpetch, P., Dineen, R., & Stewart, P. M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa008 · Cited by 347
“However, in patients with ACS, a mixed picture is reported with either decreased, normal, or even increased bone formation reported alongside normal bone resorption (229,242,259-262).”
BackgroundDiagnosis and Treatment of Subclinical Hypercortisolism
Chiodini, I. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2722 · Cited by 279
Self-citationSubclinical Cushing’s syndrome in adrenal incidentalomas
Terzolo, M., Bovio, S., Reimondo, G., Pia, A., Osella, G., Borretta, G., & Angeli, A. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.008 · Cited by 179
Chiodini, I., Morelli, V., Masserini, B., Salcuni, A. S., Eller-Vainicher, C., Viti, R., Coletti, F., Guglielmi, G., Battista, C., Carnevale, V., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0468 · Cited by 168
Self-citationSubclinical hypercortisolism among outpatients referred for osteoporosis.
Chiodini, I., Mascia, M. L., Muscarella, S., Battista, C., Minisola, S., Arosio, M., Santini, S. A., Guglielmi, G., Carnevale, V., & Scillitani, A. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00006 · Cited by 162
Self-citationEller-Vainicher, C., Morelli, V., Ulivieri, F. M., Palmieri, S., Zhukouskaya, V. V., Cairoli, E., Pino, R., Naccarato, A., Scillitani, A., Beck-Peccoz, P., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1648 · Cited by 143
Self-citationMorelli, V., Eller-Vainicher, C., Salcuni, A. S., Coletti, F., Iorio, L., Muscogiuri, G., Della Casa, S., Arosio, M., Ambrosi, B., Beck-Peccoz, P., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.398 · Cited by 135
Self-citationOsteoporosis Associated with Excess Glucocorticoids
Shaker, J. L., & Lukert, B. P. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.014 · Cited by 116
Endogenous subclinical hypercortisolism: diagnostic uncertainties and clinical implications.
Tsagarakis, S., Vassiliadi, D., & Thalassinos, N. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344133 · Cited by 113
Masserini, B., Morelli, V., Bergamaschi, S., Ermetici, F., Eller-Vainicher, C., Barbieri, A. M., Maffini, M. A., Scillitani, A., Ambrosi, B., Beck-Peccoz, P., et al. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0485 · Cited by 106
Self-citationBernini, G., Moretti, A., Iacconi, P., Miccoli, P., Nami, R., Lucani, B., & Salvetti, A. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480213 · Cited by 105
EMRAL, R., UYSAL, A. R., ASIK, M., GULLU, S., CORAPCIOGLU, D., TONYUKUK, V., & ERDOGAN, G. (2003) · Endocrine Journal · doi:10.1507/endocrj.50.399 · Cited by 104
“, PTH levels were found to be higher in patients with SCS than in patients with NFA, but other bone turnover parameters like alkaline phosphatase, serum calcium and phosphate levels were not significantly different [45], and so resemble our results.”
ResultErbil, Y., Ademoğlu, E., Özbey, N., Barbaros, U., Yanık, B. T., Salmaslioğlu, A., Bozbora, A., & Özarmağan, S. (2006) · World Journal of Surgery · doi:10.1007/s00268-005-0681-x · Cited by 103
Yanase, T., Oki, Y., Katabami, T., Otsuki, M., Kageyama, K., Tanaka, T., Kawate, H., Tanabe, M., Doi, M., Akehi, Y., et al. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej17-0456 · Cited by 90
Chiodini, I., Guglielmi, G., Battista, C., Carnevale, V., Torlontano, M., Cammisa, M., Trischitta, V., & Scillitani, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031413 · Cited by 82
Self-citationSubclinical Cushing's syndrome.
Terzolo, M., Reimondo, G., Bovio, S., & Angeli, A. (2004) · Pituitary · doi:10.1007/s11102-005-4024-6 · Cited by 80
Adrenal incidentaloma: evaluation and management
Singh, P. K., & Buch, H. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.044313 · Cited by 80
Tauchmanova, L., Rossi, R., Nuzzo, V, del Puente, A., Esposito-del Puente, A., Pizzi, C., Fonderico, F., Lupoli, G., & Lombardi, G. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450241 · Cited by 79
“In conclusion, the alterations in bone turnover (5, 17 , 39) and bone density in subjects with subclinical CS are similar to those found in overt CS. These findings suggest that all subjects with any grade of endogenous cortisol excess should be evaluated for bone mass density.”
BackgroundSkeletal involvement in adult patients with endogenous hypercortisolism
Chiodini, I., Torlontano, M., Carnevale, V., Trischitta, V., & Scillitani, A. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03345601 · Cited by 78
Self-citationEller-Vainicher, C., Morelli, V., Salcuni, A. S., Torlontano, M., Coletti, F., Iorio, L., Cuttitta, A., Ambrosio, A., Vicentini, L., Carnevale, V., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0775 · Cited by 75
Self-citationMechanisms in endocrinology: endogenous subclinical hypercortisolism and bone: a clinical review
Chiodini, I., Vainicher, C. E., Morelli, V, Palmieri, S., Cairoli, E., Salcuni, A. S., Copetti, M., & Scillitani, A. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0289 · Cited by 73
Self-citationChiodini, I., Viti, R., Coletti, F., Guglielmi, G., Battista, C., Ermetici, F., Morelli, V., Salcuni, A., Carnevale, V., Urbano, F., et al. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03310.x · Cited by 72
Self-citationSalcuni, A. S., Morelli, V., Eller Vainicher, C., Palmieri, S., Cairoli, E., Spada, A., Scillitani, A., & Chiodini, I. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-0977 · Cited by 72
Self-citationSkeletal Diseases in Cushing’s Syndrome: Osteoporosis versus Arthropathy
Kaltsas, G., & Makras, P. (2010) · Neuroendocrinology · doi:10.1159/000314298 · Cited by 71
Subclinical Cushing’s syndrome
Leo, M. D., Cozzolino, A., Colao, A. A. L., & Pivonello, R. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2012.02.001 · Cited by 71
Bone loss rate in adrenal incidentalomas: a longitudinal study
Chiodini, I., Torlontano, M., Carnevale, V., Guglielmi, G., Cammisa, M., Trischitta, V., & Scillitani, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.8022 · Cited by 69
Self-citationSubclinical Cushing's syndrome
Terzolo, M., Bovio, S., Pia, A., Osella, G., Borretta, G., Angeli, A., & Reimondo, G. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000800013 · Cited by 69
The Adrenal Incidentaloma: Disease of Modern Technology and Public Health Problem
Aron, D. C. (2001) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1011580819132 · Cited by 68
Bone metabolism and mass in women with Cushing’s syndrome and adrenal incidentaloma
Francucci, C. M., Pantanetti, P., Garrapa, G. G., Massi, F., Arnaldi, G., & Mantero, F. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01602.x · Cited by 65
“…and other reports (Ekenstam et al ., 1988; Sartorio et al ., 1988b, 1996, 1998; Piovesan et al., 1994; Osella et al., 1997; Chiodini et al., 1998; Torlontano et al., 1999), with the exception of the study of Hermus et al. (1995), the levels of BGP, a marker of bone formation, are clearly reduced…”
ResultInfluentialChiodini, I., Tauchmanovà, L., Torlontano, M., Battista, C., Guglielmi, G., Cammisa, M., Colao, A., Carnevale, V., Rossi, R., Di Lembo, S., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020399 · Cited by 63
Self-citationArnaldi, G., Masini, A. M., Giacchetti, G., Taccaliti, A., Faloia, E., & Mantero, F. (2000) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2000001000007 · Cited by 62
The clinical significance of adrenal incidentalomas
Androulakis, I. I., Kaltsas, G., Piaditis, G., & Grossman, A. B. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02436.x · Cited by 61
Hadjidakis, D., Tsagarakis, S., Roboti, C., Sfakianakis, M., Iconomidou, V., Raptis, S. A., & Thalassinos, N. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01676.x · Cited by 60
Dietary restraint, exercise, and bone density in young women: are they related?
McLEAN, J. A., BARR, S. I., & PRIOR, J. C. (2001) · Medicine and Science in Sports and Exercise · doi:10.1097/00005768-200108000-00008 · Cited by 60
Bertherat, J., Mosnier-Pudar, H., & Bertagna, X. (2002) · Current Opinion in Oncology · doi:10.1097/00001622-200201000-00011 · Cited by 60
Adrenal incidentalomas — a continuing management dilemma
Nawar, R., & Aron, D. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.00951 · Cited by 55
Osella, G., Reimondo, G., Peretti, P., Alì, A., Paccotti, P., Angeli, A., & Terzolo, M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7178 · Cited by 54
Barr, S. I., Petit, M. A., Vigna, Y. M., & Prior, J. C. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.5.940 · Cited by 50
Osteopathy in mild adrenal Cushing’s syndrome and Cushing disease
Frara, S., Allora, A., di Filippo, L., Formenti, A. M., Loli, P., Polizzi, E., Tradati, D., Ulivieri, F. M., & Giustina, A. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101515 · Cited by 47
Modern management of mild autonomous cortisol secretion
Delivanis, D. A., Athimulam, S., & Bancos, I. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1551 · Cited by 46
“However, several other studies did not find a reduction in bone formation as measured by osteocalcin(88,89) and PINP concentrations.(85,90) These conflicting results may be attributed to the small sample sizes, differences in proportions of hypogonadal patients, and heterogeneity in criteria used to define MACS.”
ResultPossible, probable, and certain hypercortisolism: A continuum in the risk of comorbidity
Castro, M. A., Corrales, E. P., & Lamas, C. (2023) · Annales d Endocrinologie · doi:10.1016/j.ando.2023.01.005 · Cited by 43
The Impact of Mild Autonomous Cortisol Secretion on Bone Turnover Markers
Athimulam, S., Delivanis, D. A., Thomas, M. A., Young, W. F., Khosla, S., Drake, M. T., & Bancos, I. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa120 · Cited by 43
Endocrine incidentalomas—challenges imposed by incidentally discovered lesions
Vassiliadi, D. A., & Tsagarakis, S. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.92 · Cited by 39
Osella, G., Ventura, M., Ardito, A., Allasino, B., Termine, A., Saba, L., Vitetta, R., Terzolo, M., & Angeli, A. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0957 · Cited by 37
Kann, P., Laudes, M., Piepkorn, B., Heintz, A., & Beyer, J. (2001) · Clinical Rheumatology · doi:10.1007/s100670170099 · Cited by 34
“Nevertheless, the findings presented in this study and documented in the literature [17] seem to be interesting enough to warrant further study, including a more intensive evaluation of the hypothalamopituitaryadrenal axis in more detail in such patients.”
BackgroundResultInfluentialEvaluation of bone health in patients with adrenal tumors
Athimulam, S., & Bancos, I. (2019) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000478 · Cited by 34
Prediction of Vertebral Fractures in Patients With Monolateral Adrenal Incidentalomas
Morelli, V., Eller-Vainicher, C., Palmieri, S., Cairoli, E., Salcuni, A. S., Scillitani, A., Carnevale, V., Corbetta, S., Arosio, M., Della Casa, S., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1423 · Cited by 33
Self-citationBiochemical bone turnover markers in hormonal disorders in adults: a narrative review
Szulc, P. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01269-7 · Cited by 32
Moraes, A. B., de Paula, M. P., Paranhos‐Neto, F. D. P., Cavalari, E. M. R., de Morais, F. F. C., Curi, D., Lima, L. F. C., de Mendonça, L. M. C., Farias, M. L. F., Madeira, M., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa263 · Cited by 32
Terzolo, M. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.3.1310 · Cited by 31
A multidisciplinary approach to the management of adrenal incidentaloma
Voltan, G., Boscaro, M., Armanini, D., Scaroni, C. M., & Ceccato, F. (2021) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1948327 · Cited by 30
Siggelkow, H., Etmanski, M., Bozkurt, S., Groβ, P., Koepp, R., Brockmöller, J., & Tzvetkov, M. V. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1418 · Cited by 29
Evaluation of Functional and Malignant Adrenal Incidentalomas
Ng, V., Ma, R. C. W., So, W.-Y., Choi, K. C., Kong, A. P. S., Cockram, C. S., & Chow, C. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.441 · Cited by 27
Imaging of adrenal incidentaloma: Our experience
Reginelli, A., Grezia, G. D., Izzo, A., D’Andrea, A., Gatta, G., Cappabianca, S., Squillaci, E., & Grassi, R. (2014) · International Journal of Surgery · doi:10.1016/j.ijsu.2014.05.029 · Cited by 25
Pal, R., Banerjee, M., Prasad, T. N., Walia, R., Bhadada, T., Singh, J., & Bhadada, S. K. (2024) · Journal of Bone and Mineral Research · doi:10.1093/jbmr/zjae067 · Cited by 25
Bardet, S., Rohmer, V., de Casson, F. B., Coffin, C., Ronci, N., Sabatier, J., Lecomte, P., Audran, M., Henry-Amar, M., & Tabarin, A. (2002) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(02)00606-9 · Cited by 23
Comorbidities in Mild Autonomous Cortisol Secretion – A Clinical Review of Literature
Czapla-Iskrzycka, A., Świątkowska−Stodulska, R., & Sworczak, K. (2022) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1827-4113 · Cited by 23
Health-related quality of life and fatigue in patients with adrenal incidentaloma
Kaštelan, D., Džubur, F., Dušek, T., Poljičanin, T., Crnčević-Orlić, Ž., Kraljević, I., Solak, M., Bencevic, T., Aganović, I., Knežević, N., et al. (2011) · Endocrine · doi:10.1007/s12020-011-9456-3 · Cited by 21
Reyes‐García, R., Gimeno, E. J., Martín, A. G., Muñoz, M. R., Sáez, J. M. G., Fernández, I. L., Varsavsky, M., Iglesias, S. G., Rodríguez, I. C., Ballesteros-Pomar, M. D., et al. (2012) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2012.01.002 · Cited by 21
Prevention of glucocorticoid-induced osteoporosis
van Brussel, M., Bultink, I. E. M., & Lems, W. F. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902868225 · Cited by 20
Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives
Altieri, B., Muscogiuri, G., Paschou, S. Α., Vryonidou, A., Casa, S. D., Pontecorvi, A., Faßnacht, M., Ronchi, C. L., & Newell-Price, J. D. C. (2018) · Endocrine · doi:10.1007/s12020-018-1696-z · Cited by 17
Adrenal incidentalomas: Surgical treatment in 28 patients and update of the literature
Porcaro, A. B., Novella, G., Ficarra, V., Curti, P., Antoniolli, S. Z., Suangwoua, H. S., & MALOSSINI, G. (2001) · International Urology and Nephrology · doi:10.1023/a:1017587312369 · Cited by 16
Relationship between type 2 diabetes mellitus and hypothalamic-pituitary-adrenal axis
Felšöci, M., Schroner, Z., Petrovičová, J., & Lazúrová, I. (2010) · Wiener klinische Wochenschrift · doi:10.1007/s00508-010-1497-8 · Cited by 13
Ishida, A., Igarashi, K., Ruike, Y., Ishiwata, K., Naito, K., Kono, S., Deguchi, H., Fujimoto, M., Shiga, A., Suzuki, S., et al. (2020) · Clinical Endocrinology · doi:10.1111/cen.14385 · Cited by 12
Incidentaloma, glucocorticoid excess and low bone mineral density: a coincidence?
Devogelaer, J. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450237 · Cited by 9
Angeli, A., Osella, G., Reimondo, G., & Terzolo, M. (2002) · KARGER eBooks · doi:10.1159/000061074 · Cited by 8
Reyes‐García, R., Gimeno, E. J., Martín, A. G., Muñoz, M. R., Sáez, J. M. G., Fernández, I. L., Varsavsky, M., Iglesias, S. G., Rodríguez, I. C., Ballesteros-Pomar, M. D., et al. (2012) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2012.01.004 · Cited by 7
Gianotti, L., Tassone, F., Pia, A. R., Bovio, S., Reimondo, G., Visconti, G., Terzolo, M., & Borretta, G. (2009) · Calcified Tissue International · doi:10.1007/s00223-009-9245-7 · Cited by 6
Unveiling the hidden impact: Subclinical hypercortisolism and its subtle influence on bone health
Lou, Y., Ren, L., Chen, H., Zhang, T., & Pan, Q. (2024) · Aging Medicine · doi:10.1002/agm2.12286 · Cited by 6
Majnik, J., Szücs, N., Patócs, A., Tóth, M., Balogh, K., Varga, I., Gláz, E., & Rácz, K. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03347517 · Cited by 6
Pathophysiology and evaluation of bone health in adrenal diseases
Uygur, M. M., di Filippo, L., Frara, S., Menotti, S., & Giustina, A. (2025) · Endocrine · doi:10.1007/s12020-025-04260-5 · Cited by 5
Turcu, A. F., & Auchus, R. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-45950-9_10 · Cited by 4
Trandafir, A.-I., Stanciu, M., Albu, S. E., Stoian, V. R., CIOFU, I., Persu, C., Nistor, C., & Carşote, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12134244 · Cited by 2
"Diagnóstico e tratamento das massas adrenais clinicamente silenciosas: revisão de literatura"
Sette, M. J. A. (2005) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2005.tde-21122005-154758 · Cited by 1
Management of adrenal incidentaloma
Kaštelan, D. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.11.75 · Cited by 1
Síndrome de Cushing subclínico
Salvador, J., gÓmez, F., & Santos, E. (2004) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(04)74618-5 · Cited by 1
Beiseigel, J. M. (2003) · VTechWorks (Virginia Tech) · Cited by 1
Zhang, C. D., Saini, J., Singh, S., Suresh, M., Thangamuthu, K., Nathani, R., Ebbehøj, A. L., Fell, V. M., Achenbach, S. J., Atkinson, E. J., et al. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag175 · Cited by 1
Masse surrenaliche incidentali: protocollo diagnostico
Arnaldi, G., & Mantero, F. (2000) · L Endocrinologo · doi:10.1007/bf03344371
Osteoporosi e ipercortisolismo subclinico
Morelli, V., Palmieri, S., & Chiodini, I. (2011) · L Endocrinologo · doi:10.1007/bf03344854
Self-citationSubclinical Hypercortisolism among Polycythemia Vera Patients
Bilgir, O., Kebapçılar, L., Alacacıoğlu, İ., Bilgir, F., Yıldız, Y., Yüksel, A., & Sarı, İ. (2010) · Internal Medicine · doi:10.2169/internalmedicine.49.2763
ADRENAL INCIDENTALOMA CASES: CLINICAL, LABORATORY AND IMAGING CHARACTERISTICS OF 62 PATIENTS
Emral, R., Gedik, V. T., ÖNÜR, D., Çorapçıoğlu, D., & Aydıntuğ, S. (2003) · Journal of Ankara Medical School · doi:10.1501/jms_0000000047
Trandafir, A.-I., Stanciu, M., Valea, A., Sima, O.-C., Nistor, C., Iliescu, M. G., Ciobanu, I., Popa, F. L., & Carşote, M. (2024) · Balneo and PRM Research Journal · doi:10.12680/balneo.2024.692
Le syndrome de Cushing infraclinique en cardiologie
Amar, J. (2010) · Archives des Maladies du Coeur et des Vaisseaux - Pratique · doi:10.1016/s1261-694x(10)70144-9
Etmanski, M. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7258
El hueso en el hipercortisolismo endógeno y exógeno
Martín, A. G., & Reyes‐García, R. (2014) · Elsevier eBooks · doi:10.1016/b978-84-9022-503-5.00008-3
Risk Factors for Osteoporotic Vertebral Fracture in Cushing Syndrome
Lee, S.-H., Park, B.-M., Song, K.-S., Lee, S.-K., Yoon, S.-P., Lee, C.-C., Lee, B.-S., & Yang, B.-S. (2017) · Journal of Korean society of spine surgery · doi:10.4184/jkss.2017.24.1.1
Síndrome de cushing subclínica em incidentalomas adrenais: do desafio do diagnóstico à terapêutica
Fernandes, S. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Metadata
- Authors
- Torlontano, M., Chiodini, I., Pileri, M., Guglielmi, G., Cammisa, M., Modoni, S., Carnevale, V., Trischitta, V., & Scillitani, A.
- Affiliations
- Casa Sollievo della Sofferenza (IT)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1999-07
- Volume
- 84
- Issue
- 7
- Pages
- 2381-2385
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2140162560
- Cited by
- 91
- References
- 30
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 1 · 2021: 2 · 2020: 5 · 2019: 3 · 2018: 2 · 2017: 1 · 2016: 3 · 2015: 1 · 2014: 2 · 2013: 1 · 2012: 5
- FWCI
- 7.50
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- adrenal incidentaloma, subclinical hypercortisolism, bone mineral density, bone turnover, osteocalcin, parathyroid hormone, female patients, C-terminal telopeptide, deoxypyridinoline, bone metabolism
- MeSH terms
- Adrenal Gland Neoplasms, Adult, Aged, Amino Acids, Collagen, Creatinine, Female, Femur, Humans, Hydrocortisone, Middle Aged, Peptides, Spine, Bone Density, Osteocalcin, Bone Remodeling, Collagen Type I
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.